Catalent stock faces uncertainty as several pharma companies voice concern about potential limited competition following the ...

Eli Lilly (LLY) is reportedly preparing to launch Mounjaro in Denmark, the home country of its leading rival in the ...

A new study is adding to evidence that GLP-1 drugs such as Novo Nordisk's semaglutide and Eli Lilly's tirzepatide could also ...

Semaglutide, found in Novo Nordisk's Ozempic, may reduce Alzheimer's risk in type 2 diabetes patients, per new research. FDA ...

Novo Nordisk’s blockbuster drug Ozempic (NVO) is linked to yet another health benefit. This time it’s lowering the risk of ...

Novo Nordisk (NVO) has asked the FDA to ban cheap copies of its weight loss drugs Wegovy and Ozempic, arguing they pose safety risks, ...

Hims & Hers (NYSE: HIMS) fell as much as 12% in trading on Wednesday after pharmaceutical company Novo Nordisk (NYSE: NVO) ...

On Wednesday, Enphase Energy (ENPH) traded at lows not seen in a year. ENPH stock fell by 14.9% to close at $78.47. In the third quarter, Enphase reported a 30.9% Y/Y drop in revenue to $380.87 ...

The full-year cost of care for U.S. patients with obesity two years after starting on Novo Nordisk’s Wegovy or similar GLP-1 ...

Earlier this month, I included a “spoiler alert” in one of our notes saying that we’d talk more about healthcare stocks. Today is that day. When it comes to an ETF, the Health Care Select Sector SPDR ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.